Clinical Trial Update: Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial, MK-0476-513, investigating ventilatory heterogeneity in participants with asthma, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MK-0476-513

Snippet

Sponsor: Hal C Charles | Conditions: Asthma | Phase 1 | Status: COMPLETED